1990
DOI: 10.1007/bf00193188
|View full text |Cite
|
Sign up to set email alerts
|

Linkage disequilibrium between DNA polymorphisms within the porphobilinogen deaminase gene

Abstract: Three restriction fragment length polymorphisms (RFLPs) (MspI, PstI, ScrFI/BstNI) within the human porphobilinogen deaminase (PBG-D) gene have been studied in 47 unrelated patients with the autosomal dominant disorder, acute intermittent porphyria (AIP), and in 92 control subjects. Each enzyme identified a two-allele polymorphism with allele frequencies close to 0.50: however, marked linkage disequilibrium limited the number of observed haplotypes to four, of which one is uncommon. No association was detected … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
8
0

Year Published

1991
1991
2000
2000

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 16 publications
(8 citation statements)
references
References 14 publications
0
8
0
Order By: Relevance
“…The identification and characterization of the mutations in the HMB-synthase gene causing ALP have increased our understanding of the molecular basis of variant AEP (22, 23), identified the molecular heterogeneity underlying both the classical and variant forms (29)(30)(31)(32)(33)(34)(35)(36)(37)(38)(39)(40)(41), permitted the precise diagnosis of asymptomatic heterozygotes (22,23,(29)(30)(31)(32)(33)(34)(35)(36)(37)(38)(39)(40)(41), and opportunity for structure-function correlations of the human enzyme. Here, six new mutations in the HMB-synthase gene are described which further increase our understanding of the molecular basis of AIP and the synthesis, structure, and function of this heme biosynthetic enzyme.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…The identification and characterization of the mutations in the HMB-synthase gene causing ALP have increased our understanding of the molecular basis of variant AEP (22, 23), identified the molecular heterogeneity underlying both the classical and variant forms (29)(30)(31)(32)(33)(34)(35)(36)(37)(38)(39)(40)(41), permitted the precise diagnosis of asymptomatic heterozygotes (22,23,(29)(30)(31)(32)(33)(34)(35)(36)(37)(38)(39)(40)(41), and opportunity for structure-function correlations of the human enzyme. Here, six new mutations in the HMB-synthase gene are described which further increase our understanding of the molecular basis of AIP and the synthesis, structure, and function of this heme biosynthetic enzyme.…”
Section: Discussionmentioning
confidence: 99%
“…Lymphoid cell lines were established and maintained as described previously (52). From each proband, erythrocyte lysates were assayed for HMB-synthase activity (21) and genomic DNA was extracted from peripheral blood (53,54) for detection of known HMB-synthase mutations (IVSI-1, IVSI+1, Q15SX, R167Q, R167W, R173Q, W198X, and IVSI2-1) as described previously (29)(30)(31)(32)(33)(34)(35).…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…Four intragenic restriction fragment length polymorphisms (Msp I, Pst I, BstNI, and ApaLI) in the PBGD gene have been successfully used for haplotype analysis including carrier detection in AIP families (3)(4)(5). Several point mutations of the PBGD gene have been identified in phenotypically different AIP patients (6)(7)(8)(9). However, none ofthe mutations so far identified has been found to occur more frequently than any of the others.…”
mentioning
confidence: 99%
“…Actually, several point mutations within the PBGD gene have been identified in AIP patients with different phenotypes (6)(7)(8)(9). However, many of those mutations appear to be unique for a family.…”
mentioning
confidence: 99%